Cited by

• Breast Cancer Risk Assessment Tool (BCRAT) and long-term breast cancer mortality in the Women's Health Initiative.

  Nelson RA, Chlebowski RT, Pan K, Rohan TE, Mortimer J, Wactawski-Wende J, Lane DS, Kruper L. Nelson RA, et al. Breast Cancer Res Treat. 2024 Sep 10. doi: 10.1007/s10549-024-07470-z. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39254768
• Breast Cancer Prevention: Time for Change.

  Chlebowski RT, Aragaki AK, Pan K. Chlebowski RT, et al. JCO Oncol Pract. 2021 Dec;17(12):709-716. doi: 10.1200/OP.21.00343. Epub 2021 Jul 28. JCO Oncol Pract. 2021. PMID: 34319769 Free PMC article.
• Understanding low chemoprevention uptake by women at high risk of breast cancer: findings from a qualitative inductive study of women's risk-reduction experiences.

  Padamsee TJ, Hils M, Muraveva A. Padamsee TJ, et al. BMC Womens Health. 2021 Apr 16;21(1):157. doi: 10.1186/s12905-021-01279-4. BMC Womens Health. 2021. PMID: 33863327 Free PMC article.
• Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.

  Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, Sattari M, Prentice RL. Chlebowski RT, et al. JAMA. 2020 Jul 28;324(4):369-380. doi: 10.1001/jama.2020.9482. JAMA. 2020. PMID: 32721007 Free PMC article. Clinical Trial.
• Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial.

  Chlebowski RT, Aragaki AK, Anderson GL, Pan K, Neuhouser ML, Manson JE, Thomson CA, Mossavar-Rahmani Y, Lane DS, Johnson KC, Wactawski-Wende J, Snetselaar L, Rohan TE, Luo J, Barac A, Prentice RL; Women’s Health Initiative. Chlebowski RT, et al. J Clin Oncol. 2020 May 1;38(13):1419-1428. doi: 10.1200/JCO.19.00435. Epub 2020 Feb 7. J Clin Oncol. 2020. PMID: 32031879 Free PMC article. Clinical Trial.